Fifth Third Bancorp
EDIT icon

Fifth Third Bancorp’s Editas Medicine EDIT Stock Holding History

Fifth Third Bancorp’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$2K – 2676
2022
Q3 		$2K Hold
200
– – ﹤0.01% 2418
2022
Q2 		$2K Buy
+200
New +$2.68K ﹤0.01% 2427
2022
Q1 		– Sell
-200
Closed -$5K – 2691
2021
Q4 		$5K Buy
200
+135
+208% +$4.65K ﹤0.01% 2320
2021
Q3 		$3K Buy
+65
New +$3.56K ﹤0.01% 2333
2019
Q1 		– Sell
-2
Closed – – 2184
2018
Q4 		$0 Buy
+2
New +$54 ﹤0.01% 2247
2018
Q3 		– Sell
-125
Closed -$4K – 2219
2018
Q2 		$4K Buy
+125
New +$4.43K ﹤0.01% 2080

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fifth Third Bancorp's EDIT Position: Q4 2022 in Review

Fifth Third Bancorp sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 200 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in EDIT in Q2 2018 and held it in 6 quarters. The position peaked at $5K in Q4 2021. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Fifth Third Bancorp reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Fifth Third Bancorp sold 200 Editas Medicine shares in Q4 2022, an estimated $2K.
  • Fifth Third Bancorp first reported a position in Editas Medicine in Q2 2018 and held it in 6 quarters.
  • Fifth Third Bancorp's Editas Medicine position peaked at $5K in Q4 2021.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Fifth Third Bancorp's 13F filing for Q4 2022, filed 25 Jan 2023.